Methylphenidate Hydrochloride
Product Images NDC 43598-438

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 43598-438). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container1 (Container1)

This appears to be a label of medication called "Methylphenidate Hydrochloride Extended-Release Tablets" with information including the quantity of 100 tablets and dosage of 18mg. The label also includes a reference to "Dr. Roddys" and two sets of alphanumeric code (one possibly a location) "NG 45595 43801" and "ShpuaioiouB 3 36105 B o". Without further context, the purpose or efficacy of this medication or the significance of the codes cannot be determined.*

FDA Label Image

Container2 (Container2)

This text is a label of a medicine bottle. The medicine is Methylphenidate Hydrochloride Extended-Release Tablets, with a strength of 27 mg. The bottle contains 100 tablets and was likely filled by a pharmacy called Dr. Roddys.*

FDA Label Image

Container3 (Container3)

This is a medication label for Methylphenidate Hydrochloride Extended-Release Tablets at a strength of 36 mg.*

FDA Label Image

Container4 (Container4)

The text indicates the details of a medication called Methylphenidate Hydrochloride Extended-Release Tablets, which come in a 54 mg dosage. The manufacturer of the tablets is mentioned as "DrRoddys", but no further information is provided.*

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

The text describes a study using extended-release tablets of Methylphenidate Hydrochloride to treat symptoms of inattention and overactivity in individuals. The dosage was a maximum of 15 7| BN tablets once daily, compared to a placebo. The study included three weeks, and the efficacy was measured using the Inattention/Overactivity Scale. The results showed a significant reduction in symptoms in the Methylphenidate Hydrochloride group compared to the placebo group in all three weeks of the study.*

FDA Label Image

Figure3 (Figure3)

This appears to be a table or chart showing the results of a study involving a drug called Attentive 2.0, specifically comparing the effects of the drug to a placebo. The drug in question is Methylphenidate Hydrochloride Extended-Release Tablets, which is taken once a day. The chart appears to show the results of testing the drug and the placebo over a period of time after the initial dose. However, there is not enough information to fully understand the study or draw any conclusions from it.*

FDA Label Image

Structure (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.